Depression predicts persistence of paranoia in clinical high-risk patients to psychosis: results of the EPOS project

Social Psychiatry and Psychiatric Epidemiology

Volumn 51, Issue 2, 2016, Pages 247-257

  Salokangas, Raimo K R ^a   Schultze Lutter, Frauke ^b   Hietala, Jarmo ^a,c   Heinimaa, Markus ^a   From, Tiina ^a   Ilonen, Tuula ^a   Löyttyniemi, Eliisa ^a   von Reventlow, Heinrich Graf ^d   Juckel, Georg ^e   Linszen, Don ^f,g   Dingemans, Peter ^f,h   Birchwood, Max ⁱ   Patterson, Paul ^j   Klosterkötter, Joachim ^k   Ruhrmann, Stephan ^k  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Turku Psychiatric Clinic   (Finland)

^d Ev Zentrum für Beratung und Therapie am Weißen Stein   (Germany)

^e RUHR UNIVERSITY BOCHUM   (Germany)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

^g MAASTRICHT UNIVERSITY   (Netherlands)

^h Mediant   (Netherlands)

ⁱ UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^j BIRMINGHAM AND SOLIHULL MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^k UNIVERSITY OF COLOGNE   (Germany)

more..

Author keywords

Anxiety; Clinical high risk; Depression; Paranoia; Persistence

Indexed keywords

ADOLESCENT; ADULT; DEPRESSIVE DISORDER; FEMALE; FOLLOW UP; HUMAN; MALE; PARANOID DISORDERS; PERSONALITY TEST; PSYCHOLOGICAL INTERVIEW; PSYCHOLOGICAL RATING SCALE; PSYCHOTIC DISORDERS; RISK ASSESSMENT; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; PARANOID DISORDERS; PERSONALITY INVENTORY; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 84957962246     PISSN: 09337954     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00127-015-1160-9     Document Type: Article

References (45)

1. Freeman D (2007) Suspicious minds: the psychology of persecutory delusions. Clin Psychol Rev 27:425–457
2. Kraepelin E (1899) Psychiatrie. Sechste, vollständig umgearbaitete Auflage. Leibzig, Johan Ambrosius Barth, Ein Lehrbuch für Studierende und Aerzte, p 1899
3. Souery D, Zaninotto L, Calati R, Linotte S, Mendlewicz J, Sentissi O, Serretti A (2012) Depression across mood disorders: review and analysis in a clinical sample. Compr Psychiatry 53:24–38
4. Manschreck TC, Khan NL (2006) Recent advances in the treatment of delusional disorder. Can J Psychiatry 51:114–119
5. de Portugal E, González N, Haro JM, Autonell J, Cervilla JA (2008) A descriptive case-register study of delusional disorder. Eur Psychiatry 23:125–133
6. Bentall RP, Corcoran R, Howard R, Blackwood N, Kinderman P (2001) Persecutory delusions: a review and theoretical integration. Clin Psychol Rev 21:1143–1192
7. Bebbington P, Jonas S, Kuipers E, King M, Cooper C, Brugha T, Meltzer H, McManus S, Jenkins R (2011) Childhood sexual abuse and psychosis: data from a cross-sectional national psychiatric survey in England. Br J Psychiatry 199:29–37
8. Häfner H, Maurer K (1991) Are there two types of schizophrenia? True onset and sequence of positive and negative syndromes prior to the first admission. In: Marneros A, Andreasen NC, Tsuan MT (eds) Negative versus positive schizophrenia. Springer, Berlin, pp 134–159
9. Svirskis T, Korkeila J, Heinimaa M, Huttunen J, Ilonen T, Ristkari T, McGlashan T, Salokangas RK (2005) Axis-I disorders and vulnerability to psychosis. Schizophr Res 75:439–446
10. Salokangas RKR, Ruhrmann S, Graf von Reventlow H, Heinimaa M, Svirskis T, From T, Luutonen S, Juckel G, Linszen D, Dingemans P, Birchwood M, Patterson P, Schultze-Lutter F, Klosterkötter J, The EPOS Group (2012) Axis I diagnoses and transition to psychosis in clinical high-risk patients. EPOS project: prospective follow-up of 245 clinical high-risk out-patients in four countries. Schizophr Res 138:192–197
11. Zhang T, Li H, Woodberry KA, Seidman LJ, Zheng L, Li H, Zhao S, Tang Y, Guo Q, Lu X, Zhuo K, Qian Z, Chow A, Li C, Jiang K, Xiao Z, Wang J (2014) Prodromal psychosis detection in a counseling center population in China: an epidemiological and clinical study. Schizophr Res 152:391–399
12. Fusar-Poli P, Nelson B, Valmaggia L, Yung AR, McGuire PK (2014) Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr Bull 40:120–131
13. Klosterkötter J, Ruhrmann S, Schultze-Lutter F, Salokangas RKR, Linszen D, Birchwood M, Juckel G, Morrison A, Vázquèz-Barquero Hambrecht M, von Reventlow H, The EPOS Group (2005) The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe. World Psychiatry 4:161–167
14. Ruhrmann S, Schultze-Lutter F, Salokangas RKR, Heinimaa M, Linszen D, Dingemans P, Birchwood M, Patterson P, Juckel G, Heinz A, Morrison A, Lewis S, Graf von Reventlow H, Klosterkötter J (2010) Prediction of psychosis in adolescents and young adults at high risk: results from the Prospective European Prediction of Psychosis Study. Arch Gen Psychiatry 67:241–251
15. Schultze-Lutter F, Klosterkötter J (2002) Bonn scale for assessment of basic symptoms—prediction list, BSABS-P. University of Cologne, Cologne
16. McGlashan TH, Miller TJ, Woods SW et al (2001) Structured interview for prodromal syndromes (Version 3.0, unpublished manuscript). New Haven, Connecticut, PRIME Research Clinic, Yale School of Medicine
17. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC
18. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276
19. Patterson P. Skeate A. Schultze-Lutter F, von Reventlow H (2002) Trauma and Distress Scale, TADS—EPOS version 1.2. 2002
20. Raine A (1991) The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull 17:555–564
21. Cutting J (1997) Principles of psychopathology: two worlds-two minds-two hemispheres. Oxford University Press, Oxford
22. Schultze-Lutter F, Renner F, Paruch J, Julkowski D, Klosterkötter J, Ruhrmann S (2014) Self-reported psychotic-like experiences are a poor estimate of clinician-rated attenuated and frank delusions and hallucinations. Psychopathology 47:194–201
23. Schultze-Lutter F, Michel C, Ruhrmann S, Schimmelmann BG (2014) Prevalence and clinical significance of DSM-5-attenuated psychosis syndrome in adolescents and young adults in the general population: the Bern Epidemiological At-Risk (BEAR) Study. Schizophr Bull 40:1499–1508
24. Pine DS, Cohen JA (2002) Trauma in children and adolescents: risk and treatment of psychiatric sequelae. Biol Psychiatry 51:519–531
25. Varese F, Smeets F, Drukker M, Lieverse R, Lataster T, Viechtbauer W, Read J, van Os J, Bentall RP (2012) Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophr Bull 38:661–671
26. Bentall RP, Wickham S, Shevlin M, Varese F (2012) Do specific early life adversities lead to specific symptoms of psychosis? A study from the 2007 the Adult Psychiatric Morbidity Survey. Schizophr Bull 38:734–740
27. Sitko K, Bentall RP, Shevlin M, O’Sullivan N, Sellwood W (2014) Associations between specific psychotic symptoms and specific childhood adversities are mediated by attachment styles: an analysis of the National Comorbidity Survey. Psychiatry Res 217:202–209
28. Marwaha S, Bebbington P (2015) Mood as a mediator of the link between child sexual abuse and psychosis. Soc Psychiatry Psychiatr Epidemiol 50:661–663
29. Kendler KS, Masterson CC, Davis KL (1985) Psychiatric illness in first-degree relatives of patients with paranoid psychosis, schizophrenia and medical illness. Br J Psychiatry 147:524–531
30. Manschreck TC (1989) Delusional (paranoid) disorders. In: Kaplan HI, Sadock BJ (eds) Comprehensive textbook of psychiatry/V, vol 1, 5th edn. Williams & Wilkins, Baltimore, pp 816–829
31. Fusar-Poli P, Meyer-Lindenberg A (2013) Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [18F]/[11C] DOPA PET studies. Schizophr Bull 39:33–42
32. Hietala J, Syvälahti E, Vilkman H, Vuorio K, Räkköläinen V, Bergman J, Haaparanta M, Solin O, Kuoppamäki M, Eronen E, Ruotsalainen U, Salokangas RK (1999) Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia. Schizophr Res 35:41–50
33. Howes OD, Montgomery AJ, Asselin MC, Murray RM, Valli I, Tabraham P, Bramon-Bosch E, Valmaggia L, Johns L, Broome M, McGuire PK, Grasby PM (2009) Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry 66:13–20
34. Howes OD, Bose SK, Turkheimer F, Valli I, Egerton A, Valmaggia LR, Murray RM, McGuire P (2011) Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am J Psychiatry 168:1311–1317
35. Laruelle M (2003) Dopamine transmission in schizophrenic brain. In: Hirsch SR, Weinberger D (eds) Schizophrenia, 2nd edn. Blackwell Science Ltd, Bath, pp 365–387
36. Morgante L, Colosimo C, Antonini A, Marconi R, Meco G, Pederzoli M, Pontieri FE, Cicarelli G, Abbruzzese G, Zappulla S, Ramat S, Manfredi M, Bottacchi E, Abrignani M, Berardelli A, Cozzolino A, Paradiso C, De Gaspari D, Morgante F, Barone P, PRIAMO Study Group (2012) Psychosis associated to Parkinson’s disease in the early stages: relevance of cognitive decline and depression. J Neurol Neurosurg Psychiatry 83:76–82
37. Freeman D, Dunn G, Murray RM, Evans N, Lister R, Antley A, Slater M, Godlewska B, Cornish R, Williams J, Di Simplicio M, Igoumenou A, Brenneisen R, Tunbridge EM, Harrison PJ, Harmer CJ, Cowen P, Morrison PD (2015) How cannabis causes paranoia: using the intravenous administration of ∆9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoia. Schizophr Bull 41:391–399
38. Wood JG, Joyce PR, Miller AL, Mulder RT, Kennedy MA (2002) A polymorphism in the dopamine beta-hydroxylase gene is associated with “paranoid ideation” in patients with major depression. Biol Psychiatry 51:365–369
39. Howes OD, Murray RM (2014) Schizophrenia: an integrated sociodevelopmental-cognitive model. Lancet 383:1677–1687
40. Kapur S (2003) Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 160:13–23
41. Schmidt SJ, Grunert VM, Schimmelmann BG, Schultze-Lutter F, Michel C (2014) Differences in coping, self-efficacy, and external control beliefs between patients at-risk for psychosis and patients with first-episode psychosis. Psychiatry Res 219:95–102
42. Vaswani M, Linda FK, Ramesh S (2003) Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry 27:85–102
43. Hofmann SG, Asnaani A, Vonk IJ, Sawyer AT, Fang A (2012) The efficacy of cognitive behavioral therapy: a review of meta-analyses. Cogn Ther Res 36:427–440
44. Schmidt SJ, Schultze-Lutter F, Schimmelmann BG, Maric NP, Salokangas RKR, Riecher-Rössler A, van der Gaag M, Nordentoft M, Raballo A, Meneghelli A, Marshall M, Morrison A, Klosterkötter J, Ruhrmann S (2015) EPA guidance on the early intervention in clinical high risk states of psychoses. Eur Psychiatry 30:388–404
45. Masillo A, Day F, Laing J, Howes O, Fusar-Poli P, Byrne M, Bhattacharyya S, Fiori Nastro P, Girardi P, McGuire PK, Valmaggia LR (2012) Interpersonal sensitivity in the at-risk mental state for psychosis. Psychol Med 42:1835–1845